Aurinia Pharmaceuticals (AUPH) Other financing activities (2024 - 2026)
Aurinia Pharmaceuticals' Other financing activities was $11.87 million in Q2 2026, compared with $103,000 a year earlier and down 18.6% from the prior quarter.
Powered by 
Analysis
Aurinia Pharmaceuticals (AUPH) Other financing activities (2024 - 2026) Analysis & Trends
On a trailing twelve-month basis, Aurinia Pharmaceuticals' Other financing activities was $27.18 million through Jun 30, 2026, up 187.8% year-over-year; for FY2025, it was $9.76 million, up 59.2% from FY2024.
- Other financing activities has now increased for three consecutive years, with a three-year compound annual growth rate of 111.0% (FY2022 to FY2025).
- In earlier years, Other financing activities was $6.13 million in FY2024 (+169.2%), $2.28 million in FY2023 (+119.1%) and $1.04 million in FY2022.
- Quarterly Other financing activities has moved between $103,000 (Q2 2025) and $14.58 million (Q1 2026) over five years.
- Compared with a year earlier, Other financing activities was higher in four of the last five quarters, with growth averaging 47.8%.
- Per Business Quant data, AUPH's Other financing activities in the three quarters before Q2 2026 was $14.58 million (Q1 2026), $364,000 (Q4 2025) and $364,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Aurinia Pharmaceuticals | 2.18 Bn | 608.45 Mn | 76.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.87 Mn |
| Mar 31, 2026 | -14.58 Mn |
| Dec 31, 2025 | -364,000.00 |
| Sep 30, 2025 | -364,000.00 |
| Jun 30, 2025 | -103,000.00 |
| Mar 31, 2025 | -8.93 Mn |
| Dec 31, 2024 | -242,000.00 |
| Sep 30, 2024 | -167,000.00 |
| Jun 30, 2024 | -229,000.00 |
| Mar 31, 2024 | -5.50 Mn |
API Access
Aurinia Pharmaceuticals Other financing activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=AUPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "AUPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=AUPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();